These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 37031089)

  • 1. An Exploratory Study of the PrEP Modality Preferences Among a Convenience Sample of Parents of Sexual and Gender Minority Adolescents.
    Owens C; Carter K; Grant MJ; Hubach RD; Hoffman M
    J Adolesc Health; 2023 Oct; 73(4):625-631. PubMed ID: 37031089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parental Concerns of Their Sexual and Gender Minority Adolescents Using HIV Pre-Exposure Prophylaxis.
    Owens C; Brandenburg D; Grant MJ; Carter K; Hoffman M; Hubach RD
    AIDS Educ Prev; 2023 Feb; 35(1):85-99. PubMed ID: 36735230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Willingness to use and preferences for long-acting injectable PrEP among sexual and gender minority populations in the southern United States, 2021-2022: cross-sectional study.
    Schoenberg P; Edwards OW; Merrill L; Martinez CA; Stephenson R; Sullivan PS; Jones J
    J Int AIDS Soc; 2023 Mar; 26(3):e26077. PubMed ID: 36951057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Awareness and Knowledge of Pre-exposure Prophylaxis Among Sexual and Gender Minority Adolescents Assigned Male at Birth in the United States.
    Matson M; Nery-Hurwit M; Crosby S; Greene GJ; Macapagal K
    Arch Sex Behav; 2021 May; 50(4):1701-1711. PubMed ID: 33982212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on and preferences for on-demand and long-acting PrEP among sexual and gender minority adolescents assigned male at birth.
    Macapagal K; Nery-Hurwit M; Matson M; Crosby S; Greene GJ
    Sex Res Social Policy; 2021 Mar; 18(1):39-53. PubMed ID: 33456624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Free Testing and PrEP without Outing Myself to Parents:" Motivation to participate in oral and injectable PrEP clinical trials among adolescent men who have sex with men.
    Fisher CB; Fried AL; Ibrahim Puri L; Macapagal K; Mustanski B
    PLoS One; 2018; 13(7):e0200560. PubMed ID: 30044845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-Generation HIV Pre-Exposure Prophylaxis Preferences Among Men Who Have Sex with Men Taking Daily Oral Pre-Exposure Prophylaxis.
    Ellison J; van den Berg JJ; Montgomery MC; Tao J; Pashankar R; Mimiaga MJ; Chan PA
    AIDS Patient Care STDS; 2019 Nov; 33(11):482-491. PubMed ID: 31603712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis Among Young Adult Sexual Minority Men and Transgender Women.
    Weeden T; Garofalo R; Johnson AK; Schnall R; Cervantes M; Scherr T; Kuhns LM
    Acad Pediatr; 2024; 24(7):1110-1115. PubMed ID: 38631476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preferences for Long-Acting Pre-exposure Prophylaxis (PrEP), Daily Oral PrEP, or Condoms for HIV Prevention Among U.S. Men Who Have Sex with Men.
    Greene GJ; Swann G; Fought AJ; Carballo-Diéguez A; Hope TJ; Kiser PF; Mustanski B; D'Aquila RT
    AIDS Behav; 2017 May; 21(5):1336-1349. PubMed ID: 27770215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability and Barriers to HIV Pre-Exposure Prophylaxis in Atlanta's Adolescents and Their Parents.
    Shah M; Gillespie S; Holt S; Morris CR; Camacho-Gonzalez AF
    AIDS Patient Care STDS; 2019 Oct; 33(10):425-433. PubMed ID: 31436485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.
    Watson DL; Listerud L; Drab RA; Lin WY; Momplaisir FM; Bauermeister JA
    J Int AIDS Soc; 2024 Feb; 27(2):e26211. PubMed ID: 38332521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferences for long-acting pre-exposure prophylaxis among gay, bisexual and other men who have sex with men in Taiwan: findings from the 2021 HEART Survey.
    Hsu JH; Ku SW; Chen TW; Li CW; Huang P; Wu HJ; Bourne A; Strong C
    J Int AIDS Soc; 2023 Sep; 26(9):e26163. PubMed ID: 37675767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient and Physician Preferences Regarding Long-Acting Pre-Exposure Prophylaxis and Antiretroviral Therapy: A Mixed-Methods Study in Southern California, USA.
    Yeager S; Montoya JL; Burke L; Chow K; Moore DJ; Morris S
    AIDS Res Hum Retroviruses; 2022 Nov; 38(11):856-862. PubMed ID: 35972754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acceptability of and Preferences for Long-Acting Injectable HIV PrEP and Other PrEP Modalities among Sexual Minority Men in Nigeria, Africa.
    Ogunbajo A; Tsai AC; Kanki PJ; Mayer KH
    AIDS Behav; 2022 Jul; 26(7):2363-2375. PubMed ID: 35061117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who prefers what? Correlates of preferences for next-generation HIV prevention products among a national U.S. sample of young men who have sex with men.
    Biello KB; Valente PK; da Silva DT; Lin W; Drab R; Hightow-Weidman L; Mayer KH; Bauermeister JA;
    J Int AIDS Soc; 2023 Jul; 26 Suppl 2(Suppl 2):e26096. PubMed ID: 37439061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protocol for a multicenter, real-world study of HIV pre-exposure prophylaxis among men who have sex with men in China (CROPrEP).
    Wang H; Zhang Y; Mei Z; Jia Y; Leuba SI; Zhang J; Chu Z; Ding H; Jiang Y; Geng W; Shang H; Xu J
    BMC Infect Dis; 2019 Aug; 19(1):721. PubMed ID: 31416439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17-24 years old.
    John SA; Zapata JP; Dang M; Pleuhs B; O'Neil A; Hirshfield S; Walsh JL; Petroll AE; Quinn KG
    Sci Rep; 2023 Mar; 13(1):5116. PubMed ID: 36991027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access to HIV Pre-exposure Prophylaxis in Practice Settings: a Qualitative Study of Sexual and Gender Minority Adults' Perspectives.
    Sun CJ; Anderson KM; Bangsberg D; Toevs K; Morrison D; Wells C; Clark P; Nicolaidis C
    J Gen Intern Med; 2019 Apr; 34(4):535-543. PubMed ID: 30719647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Exploratory Study of the Mpox Media Consumption, Attitudes, and Preferences of Sexual and Gender Minority People Assigned Male at Birth in the United States.
    Owens C; Hubach RD
    LGBT Health; 2023 Jul; 10(5):401-407. PubMed ID: 36735618
    [No Abstract]   [Full Text] [Related]  

  • 20. Awareness and Willingness to Use Biomedical Prevention Strategies for HIV Among Sexual and Gender Minority Youth: Results From a National Survey.
    Dunville R; Harper C; Johns MM; Heim Viox M; Avripas S; Fordyce E; Stern M; Schlissel A; Carpenter R; Michaels S
    J Adolesc Health; 2021 Jan; 68(1):199-206. PubMed ID: 32693984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.